Page last updated: 2024-10-24

chloroquine and EHS Tumor

chloroquine has been researched along with EHS Tumor in 2 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tokui, T1
Kuroiwa, C1
Tokui, Y1
Sasagawa, K1
Kawai, K1
Kobayashi, T1
Ikeda, T1
Komai, T1
el-Mofty, MM1
Khudoley, VV1
Sakr, SA1
Abdel-Gawad, HS1

Other Studies

2 other studies available for chloroquine and EHS Tumor

ArticleYear
Contribution of serum lipoproteins as carriers of antitumour agent RS-1541 (palmitoyl rhizoxin) in mice.
    Biopharmaceutics & drug disposition, 1994, Volume: 15, Issue:2

    Topics: Animals; Antineoplastic Agents; Autoradiography; Carbon Radioisotopes; Chloroquine; Female; In Vitro

1994
The carcinogenicity of some antimalarial drugs using the Egyptian toad Bufo regularis as a biological test animal.
    Nutrition and cancer, 1992, Volume: 18, Issue:2

    Topics: Animals; Antimalarials; Bufonidae; Chloroquine; Disease Models, Animal; Drug Combinations; Female; K

1992